The authors found that blocking IL-1 signaling could alter pro-inflammatory responses by decreasing NF-kB activity, tau pathology and some oligomeric and fibrillar forms of Aβ in 3xTg-AD mice. This evidence concerns the gene MAPT and Alzheimer disease.